14th European Congress of Clinical Microbiology and Infectious ...

Poster Sessions Sunday, May 2, 2004
P650 Restoration of complement-mediated
phagocytosis in HIV-1 infected macrophages
by 2’5’dideoxyadenosin (ddAD)
D. Doischer, A. Jaworowski, U. Frank, S. Crowe
(Freiburg, D; Melbourne, AUS)
P651 CD4+ T-lymphocytes counts at AIDS among
patients treated by highly active antiretroviral
therapy or other antiretroviral regimens
A. Gayet-Ageron, N. Voirin, D. Peyramond,
C. Chidiac, C. Trepo, J.-L. Touraine, B. Issartel,
B. Ponceau, P. Miailhes, J.-L. Livrozet, J. Fabry,
P. Vanhems (Lyon, F)
P652 Gender differences in HIV RNA and CD4
counts, but not in AIDS-defining illnesses and
CD4-based HAART initiation threshold, in new
entrants to HIV care in Cleveland, Ohio
C.V. Loupa, B. Rodriguez, H. Valdez, R.A. Salata,
M.V. Lisgaris, B. Gripshover, G. McComsey,
S. Fulton, M.M. Lederman
(Cleveland, Ridgebury, USA)
P653 Incidence and predictors of opportunistic
infections and mortality in HIV/AIDS patients
admitted to a university hospital:
a 16-year follow-up
G. Sain Güven, N. Aydemir, B. Cakir, O. Uzun,
S. Ünal (Ankara, TR)
P654 Venezuelan HIV patients and prevalence of
HPV infection in anal samples
M. Correnti, M.E. Cavazza Porro, R. Alfonso,
E. Arias, M.E. Avila, M. Uribe (Caracas, VE)
P655 HCV viraemia and the degree of hepatic
affectation in HCV-HIV co-infected patients
S. Garcinuño, I. Guilabert, T. Alvarez Gago,
M.A. del Pozo, J. Arias, B. Sánchez Borge,
M.A. Mantecón, M.A. Bratos, A. Orduña,
A. Rodríguez Torres (Valladolid, E)
P656 Prevalence of GBV-c/HGV in HIV-infected
patients and potential influence of coinfection
on the course of the disease
V. Aster, J. König, M. Stanková, H. Rozsypal,
B. Prochazka (Prague, CZ)
P657 Cardiovascular neurovegetative dysfunction
in HIV-infected patients
S. Cicalini, G. Raimondi, P. Noto, E. Boumis,
S. Sacco, C. Saltini, N. Petrosillo (Rome, I)
P658 Pancreatic abnormalities during HIV infection.
What about epidemiology, management, and
outcome?
R. Manfredi, L. Calza, F. Chiodo (Bologna, I)
P659 Laboratory and clinical pancreatic abnorm -
alities during HIV infection treated with
antiretroviral therapy
R. Manfredi, L. Calza, F. Chiodo (Bologna, I)
P660 Antiretroviral treatment and gynecomastia:
which correlations?
R. Manfredi, L. Calza, F. Chiodo (Bologna, I)
P661 Lipomatosis and HIV disease during
antiretroviral therapy
R. Manfredi, L. Calza, F. Chiodo (Bologna, I)
P662 Drug-induced alopecia after lopinavir/
ritonavir (Kaletra) treatment
G. Chrysos, A. Pastelli, S. Mikros, F. Stasini,
E. Friligou, L. Karampali, P. Spyropoulou
(Athens, GR)
P663 Modification of lipid parameters during
structured interruptions of treatment in HIV
chronically infected patiens
M. Montes de Oca Arjona, R. García Juárez,
A. Martin-Aspas, R. Perez-Cano, F. Brun Romero,
C. Fernandez Gutierrez, J. Girón-González
(Cádiz, E)
P664 Metabolic changes in HIV-infected patients on
HAART
E. Valadas, H. Chaves Ramos, J. Cruz, C. Ribeiro,
L. Caldeira, F. Antunes (Lisbon, P)
P665 Nephrolitiasis induced by indinavir plus
boosting dose of ritonavir in a Belgrade study
population
G. Dragovic, D. Jevtovic (Belgrade, CS)
P666 Prevalence of resistance mutations in subtype
F strains isolated from Romanian naïve
children
D. Otelea, S. Manaila, M. Dinu, D. Banica,
M. Tinischi, D. Maxim (Bucharest, RO)
P667 Phylogenetic analysis of subtype F HIV 1
strains isolated in Romania
D. Otelea, G. Oprisan, M. Dinu, S. Manaila, D.
Banica, M. Tinischi, D. Maxim (Bucharest, RO)
P668 Comparison of line probe assay versus
sequence analysis for detection of human
immunodeficiency virus type 1 (HIV-1)
mutations conferring resistance to
antiretroviral drugs
S. García-Bujalance, C. Ladrón de Guevara,
A. Sánchez-Maroto, A. Gutiérrez (Madrid, E)
P669 Evaluation of the Roche COBAS TaqMan
48 HIV-1 test
J. Djupsjöbacka, K. Sopenlehto, H. Piiparinen,
M. Lappalainen, J. Suni (Helsinki, FIN)
www.escmid.org/eccmid2004
page 77